New potential treatment for graft-versus-host-disease and other inflammatory disorders
Researchers have shown that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease, an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation.
Materials provided by University of California – Davis Health. Note: Content may be edited for style and length.
Source link aaaaa